Thermo Fisher Scientific Cetuximab Recombinant Rabbit Monoclonal Antibody (90G3), MonoRab
Recombinant rabbit monoclonal antibody (Clone 90G3) targeting Cetuximab for ELISA and blocking assays. High specificity to human EGFR. Lyophilized form with Protein A purification. Ideal for research use in cancer and EGFR-related studies.
- 카탈로그번호
- A0199240
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Cetuximab Recombinant Rabbit Monoclonal Antibody (90G3), MonoRab
Applications and Tested Dilution
| Application | Tested Dilution |
|---|---|
| ELISA (ELISA) | 0.01–0.1 µg/mL |
| Blocking Assay (BLOCK) | 10–50 µg/mL |
Product Specifications
| Specification | Description |
|---|---|
| Species Reactivity | Human |
| Host / Isotype | Rabbit / IgG |
| Expression System | Mammalian cells |
| Class | Recombinant Monoclonal |
| Type | Antibody |
| Clone | 90G3 |
| Immunogen | Cetuximab |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Purification | Protein A |
| Storage Buffer | PBS, pH 7.4 |
| Contains | 0.02% sodium azide |
| Storage Conditions | -20°C or -80°C if preferred |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
Product Specific Information
Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
Cetuximab is a recombinant human/mouse chimeric monoclonal antibody against epidermal growth factor receptor (EGFR). It consists of antigen-binding regions of a mouse anti-EGFR monoclonal antibody specific for the N-terminal portion of human EGFR, combined with human IgG1 heavy and kappa light chain constant regions.
Cetuximab is marketed under the brand Erbitux by Eli Lilly Company and approved by the U.S. FDA for treatment of metastatic colorectal cancer and metastatic non-small cell lung cancer.
GenScript MonoRab™ Anti-Cetuximab Antibody (90G3), mAb, Rabbit is produced from a hybridoma derived from the fusion of partner and B-lymphocytes obtained from a rabbit immunized with Cetuximab.
Target Information
Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody approved by the U.S. FDA for treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer, and head and neck cancer. As an epidermal growth factor receptor (EGFR) inhibitor, Cetuximab binds to EGFR.
For Research Use Only.
Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.